Daniel Gamalski, Ph.D.

COUNSEL, ATTORNEY-AT-LAW

Daniel is an energetic and innovative legal professional with over 25 years of experience advising at the intersection of life sciences, commercial law, and international business.

His expertise spans in-house pharmaceutical and biotech roles as well as law firm practice, covering licensing, M&A, intellectual property, compliance, regulatory affairs, and corporate governance across multiple jurisdictions. A specialist in comparative law, Daniel delivers strategic counsel that transcends individual legal systems and anticipates the full complexity of cross-border transactions.

For approximately 14 years, Daniel served as the architect of legal and compliance functions at Polpharma Biologics – one of the largest ventures of its kind in Central and Eastern Europe and the first FDA-approved biologics manufacturing site in Poland.

Having spent years embedded in business, Daniel understands firsthand what companies truly need from their legal counsel: pragmatic, forward-looking, and commercially minded advice that enables growth rather than constrains it. He now brings this perspective to clients operating in the pharmaceutical, biotech, healthcare, and life sciences sectors.

SPECIALISATION:

Life Sciences
Health
Products